Impact of minimal residual disease (MRD) in salvage autologous stem cell transplantation for relapsed myeloma: results from the NCRI Myeloma X (intensive) trial

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2024-03, Vol.59 (3), p.431-434
Hauptverfasser:	de Tute, Ruth M., Cook, Gordon, Cairns, David A., Brown, Julia M., Cavenagh, Jamie, Ashcroft, A. John, Snowden, John A., Yong, Kwee, Tholouli, Eleni, Jenner, Matthew, Hockaday, Anna, Drayson, Mark T., Morris, Treen C. M., Rawstron, Andy C., Owen, Roger G.
Format:	Artikel
Sprache:	eng
Schlagworte:	14 14/1 631/250/1904 692/308/2779/777 692/308/575 692/499 Cell Biology Correspondence Hematology Hematopoietic Stem Cell Transplantation - methods Humans Internal Medicine Medicine Medicine & Public Health Minimal residual disease Multiple Myeloma - therapy Myeloma Neoplasm Recurrence, Local Neoplasm, Residual Public Health Stem cell transplantation Stem Cell Transplantation - methods Stem Cells Transplantation, Autologous
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!